Search

Tutorial on thalassemia focused on best treatment

Almost 90 delegates from Shiraz and other cities in Iran learned how to identify the best treatment for each thalassemia patient at the EHA-SHRC Hematology Tutorial on Thalassemia on May 10-11, 2018 in Shiraz, Iran.

Read more

EHA has joined the European Cancer Organisation - a perfect match on objectives and prioritization

The European Hematology Association (EHA) has joined the European Cancer Organisation, a not-for-profit federation of organizations working in cancer at the European level.

Read more

Mini-hormone fights iron

Iron overload commonly leads to organ damage and even death. Currently available treatments for iron overload are burdensome or cause side effects.

Read more

Grants & abstract awards

EHA Travel & Participation grantsThe call for travel & participation grant applications is open as of January 1, 2024. New: Grant applications have been integrated into the EHA2024 Abstract Submission form.

Read more

Open Access: the ‘Plan S’

 

Research and academic groundwork funded with public means should be free and open to everyone. That is the principle behind Open Access that was formulated in 2003 in the Berlin Declaration.

Read more

EHA-HSHT Joint Membership

Join EHA and HSHT to receive up to €50 discount on your membershipThe European Hematology Association (EHA) and the Hungarian Society of Hematology and Transfusion (HSHT) - Magyar Hematológiai és Transzfuziológiai Társaság – MHTT, have joined forces to offer joint membership to…

Read more

EHA response to the EU’s Pharma Revision

Last week, the European Affairs team finalised EHA's response to the proposed revision of the EU (European Union) Pharmaceutical Legislation. In April 2023, the European Commission published a proposed Directive and Regulation to replace the current, outdated legal framework.

Read more